VelacurTM Data Presented at 2021 AASLD The Liver Meeting
Sonic Incytes Medical Corp. is pleased to announce that data from its sponsored clinical study of VelacurTM – the first handheld 3D liver health assessment solution – will be presented during the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting®, hosted virtually November 12-15, 2021.
Sonic Incytes Showcases VelacurTM at ACG 2021
In recognition of Liver Awareness Month this October, Sonic Incytes Medical Corp. is pleased to showcase VelacurTM, the first handheld 3D liver health assessment solution, at the American College of Gastroenterology (ACG) Annual Scientific Meeting, Oct 22-27.
Join Sonic Incytes at ACG 2021
You’re invited! Join Sonic Incytes at ACG 2021. VelacurTM, the first handheld 3D liver health assessment solution, is coming to ACG 2021. If you care for patients with chronic liver disease or are interested in building your practice, we invite you to connect with us at the ACG 2021 Annual Scientific Meeting in Las Vegas. […]
Discover VelacurTM at the Annual National Liver Conference
If you practice in the field of liver disease, visit our booth at the 16th Annual National Liver Conference to learn more about VelacurTM, the first handheld 3D liver health assessment solution. Hosted October 1, 2021, this conference is intended for physicians and other health care professionals engaged in the care of patients with liver […]
Discover How You Can Grow Your Practice with VelacurTM at TSGE 2021
VelacurTM, the first handheld 3D liver health assessment solution, is coming to the 2021 Annual TSGE Conference, September 24 to 26! If you care for patients with chronic liver disease (including fatty liver disease) or are interested in building your practice, visit our booth for a live VelacurTM demo and to connect with our team. […]
Visit VelacurTM at 2021 Annual GHAPP Conference
If you specialize in the management of patients with chronic liver disease, visit our booth at the 2021 Annual GHAPP Conference to learn more about VelacurTM, the first handheld 3D liver health assessment solution. Hosted September 9-11, the GHAPP Conference is the only conference specifically designed by and for advanced practice providers (APPs) to review […]
Register for An Optimal Model of Care for NASH Webinar
Sonic Incytes Medical Corp. is pleased to host a live educational webinar on The Multidisciplinary Approach: An Optimal Model of Care for NASH. Endocrinologist Dr. Kenneth Cusi and hepatologist Dr. Mazen Noureddin join forces to shine a light on the emerging fatty liver disease epidemic, and what it will take to overcome this health burden. […]
On a Quest to Improve Quality of Life
As a young child, Julio Lobo loved solving problems. Fast forward to today, he’s been instrumental in helping build VelacurTM, a diagnostic solution for one of the world’s biggest problems: fatty liver disease. Affecting 1 in 4 people around the world, fatty liver disease is the fastest growing and largest segment of chronic liver disease, […]
Visit VelacurTM at Advancing GI Patient Care 2021
On July 24, find out how you can improve patient care for those with chronic liver disease at Advancing GI Patient Care 2021, an educational conference hosted by GI Alliance. Visit our in-person booth for live demos of VelacurTM, the first handheld 3D liver health assessment solution. Advancing GI Patient Care 2021 will deliver focused, […]
Sonic Incytes to Present at the Venture Summit Virtual Connect
Sonic Incytes Medical Corp., the developer of VelacurTM, has been selected to present its innovative technology at the upcoming Venture Summit Virtual Connect conference, hosted by youngStartup Ventures from July 6-8, 2021. Sonic Incytes is among the top innovators from the technology, cleantech, life sciences, healthcare and fintech sectors chosen to present to an exclusive […]
